Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes

Abstract Background Long noncoding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, and associated with chronic inflammation and damage t...

Full description

Bibliographic Details
Main Authors: Bo-Wei Han, Hua Ye, Pan-Pan Wei, Bo He, Cai Han, Zhen-Hua Chen, Yue-Qin Chen, Wen-Tao Wang
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12864-018-5133-8
_version_ 1818505541612208128
author Bo-Wei Han
Hua Ye
Pan-Pan Wei
Bo He
Cai Han
Zhen-Hua Chen
Yue-Qin Chen
Wen-Tao Wang
author_facet Bo-Wei Han
Hua Ye
Pan-Pan Wei
Bo He
Cai Han
Zhen-Hua Chen
Yue-Qin Chen
Wen-Tao Wang
author_sort Bo-Wei Han
collection DOAJ
description Abstract Background Long noncoding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, and associated with chronic inflammation and damage to the biliary epithelium. This study determined whether lncRNAs were dysregulated and participated in disease diagnosis or pivotal inflammation pathways through a genome-wide lncRNA screening and functional analysis. Results We firstly identified a large number of lncRNAs abnormally expressed between 9 pairs of cancerous and adjacent tissues of CCA, and between intra-hepatic CCA and extra-hepatic CCA through a genome-wide profiling. A set of aberrant differentially expressed lncRNAs were further validated in a training set (16 pairs) and a test set (11 pairs) of CCA patient samples. Following assessment of the diagnostic value of the 7 differentially expressed lncRNAs, we confirmed the optimal combination of H19, C3P1, AC005550.3, PVT1, and LPAL2 with area under the curve of 0.8828 [95% CI: 0.7441–1.021, P < 0.001], with 93.75% sensitivity and 81.25% specificity, at the cutoff point of − 0.2884 to distinguish the CCA tissue from the normal ones, suggesting that specific lncRNAs may have potential for detecting CCA. More importantly, the genome-wide locus and lncRNA/mRNA co-expression analyses revealed a set of lncRNAs that participated in inflammation and oxidative stress response pathways by regulating genes in cis or in trans. Finally, APOC1P1, PVT1, and LPAL2 were validated to regulate the migration and some pivotal inflammation genes under the CCA pathogenesis. Conclusions Our findings are the first to show that lncRNAs may not only be potential biomarkers of CCA progression but also respond to inflammation in CCA.
first_indexed 2024-12-10T21:52:11Z
format Article
id doaj.art-cc277ec8e7d94444895fa4fd508e5641
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-12-10T21:52:11Z
publishDate 2018-10-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-cc277ec8e7d94444895fa4fd508e56412022-12-22T01:32:09ZengBMCBMC Genomics1471-21642018-10-0119111310.1186/s12864-018-5133-8Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytesBo-Wei Han0Hua Ye1Pan-Pan Wei2Bo He3Cai Han4Zhen-Hua Chen5Yue-Qin Chen6Wen-Tao Wang7MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityDepartment of Hepatobiliary, and Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityMOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityDepartment of Hepatobiliary, and Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityMOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityMOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityMOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityMOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, Sun Yat-sen UniversityAbstract Background Long noncoding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, and associated with chronic inflammation and damage to the biliary epithelium. This study determined whether lncRNAs were dysregulated and participated in disease diagnosis or pivotal inflammation pathways through a genome-wide lncRNA screening and functional analysis. Results We firstly identified a large number of lncRNAs abnormally expressed between 9 pairs of cancerous and adjacent tissues of CCA, and between intra-hepatic CCA and extra-hepatic CCA through a genome-wide profiling. A set of aberrant differentially expressed lncRNAs were further validated in a training set (16 pairs) and a test set (11 pairs) of CCA patient samples. Following assessment of the diagnostic value of the 7 differentially expressed lncRNAs, we confirmed the optimal combination of H19, C3P1, AC005550.3, PVT1, and LPAL2 with area under the curve of 0.8828 [95% CI: 0.7441–1.021, P < 0.001], with 93.75% sensitivity and 81.25% specificity, at the cutoff point of − 0.2884 to distinguish the CCA tissue from the normal ones, suggesting that specific lncRNAs may have potential for detecting CCA. More importantly, the genome-wide locus and lncRNA/mRNA co-expression analyses revealed a set of lncRNAs that participated in inflammation and oxidative stress response pathways by regulating genes in cis or in trans. Finally, APOC1P1, PVT1, and LPAL2 were validated to regulate the migration and some pivotal inflammation genes under the CCA pathogenesis. Conclusions Our findings are the first to show that lncRNAs may not only be potential biomarkers of CCA progression but also respond to inflammation in CCA.http://link.springer.com/article/10.1186/s12864-018-5133-8CCAlncRNAGenome-wideDiagnostic valueInflammatory pathway
spellingShingle Bo-Wei Han
Hua Ye
Pan-Pan Wei
Bo He
Cai Han
Zhen-Hua Chen
Yue-Qin Chen
Wen-Tao Wang
Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
BMC Genomics
CCA
lncRNA
Genome-wide
Diagnostic value
Inflammatory pathway
title Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
title_full Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
title_fullStr Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
title_full_unstemmed Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
title_short Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
title_sort global identification and characterization of lncrnas that control inflammation in malignant cholangiocytes
topic CCA
lncRNA
Genome-wide
Diagnostic value
Inflammatory pathway
url http://link.springer.com/article/10.1186/s12864-018-5133-8
work_keys_str_mv AT boweihan globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT huaye globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT panpanwei globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT bohe globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT caihan globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT zhenhuachen globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT yueqinchen globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes
AT wentaowang globalidentificationandcharacterizationoflncrnasthatcontrolinflammationinmalignantcholangiocytes